Plain-English translation of NCT05136222 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a personalized approach to setting up non-invasive ventilation (NIV)—a breathing assistance device that uses gentle air pressure through a mask—works better than the standard setup method for people with motor neuron disease. Half of participants will have their NIV settings adjusted based on detailed information from a sleep study, while the other half will receive the standard setup. The goal is to help more people use this life-extending treatment comfortably for long enough each day to get real benefits.
Many people with motor neuron disease struggle to tolerate or use breathing assistance regularly, even though it can extend their life and improve how they feel. A smaller study showed that customizing the device settings based on a sleep study helped people use it better, so this larger trial is testing whether that improvement holds true across multiple hospitals and over a longer period of time.
You likely qualify if…
You likely don't qualify if…
After about three weeks of getting used to your breathing device with standard settings, you'll spend one night in a sleep laboratory where researchers monitor your sleep and breathing while you use the device. If you're in the treatment group, your device settings will be adjusted based on what they learn that night; if you're in the comparison group, your settings won't change. You'll then continue using your device at home as directed for seven more weeks, and researchers will follow up with you for up to 12 months to see how well you're doing.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Australia